Valuation : Lord Global Corporation

Market Cap 5.28M 4.55M 4.31M 3.91M 7.33M 505M 7.36M 51.18M 19.68M 257M 19.84M 19.4M 811M P/E 2018 *
-
P/E 2019 -0.6x
Enterprise Value 5.89M 5.07M 4.8M 4.35M 8.17M 563M 8.21M 57.06M 21.94M 286M 22.12M 21.63M 905M EV / Sales 2018
1,290x
EV / Sales 2019 1,135x
Free-Float
25.63%
Yield 2018 *
-
Yield 2019 -
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0002
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0.6
10 years 0
Extreme 0
200,000
Manager TitleAgeSince
Chief Executive Officer 36 2020-01-23
Director TitleAgeSince
Chairman 36 2020-01-23
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%-.--%-.--%-.--% 372
+1.59%-2.76%-39.52%-22.07% 11.65B
-0.56%-0.73%+83.39%+125.98% 9.44B
+0.37%+3.40%-14.05%+41.49% 8.68B
+0.11%-11.81%-40.83%-36.54% 4.95B
-1.24%-1.50%-42.78%+20.63% 4.94B
+0.23%+0.23%-4.44%-3.91% 4.26B
-0.62%+3.40%-27.95%-8.40% 3.57B
+1.08%+1.21%+47.58%+52.37% 3.32B
-1.34%+20.41%-48.06%-30.75% 3.15B
Average +9.96%-0.52%-8.67%+13.88% 5.4B
Weighted average by Cap. +0.16%-1.59%-5.94%+23.05%

Financials

2018 2019
Net sales 2.83K 2.44K 2.31K 2.09K 3.92K 270K 3.94K 27.39K 10.53K 137K 10.62K 10.38K 434K 888 765.1 724.45 656.64 1.23K 84.84K 1.24K 8.6K 3.31K 43.16K 3.33K 3.26K 136K
Net income -6.43M -5.54M -5.25M -4.76M -8.92M -615M -8.97M -62.33M -23.97M -313M -24.16M -23.63M -988M -491K -423K -400K -363K -681K -46.88M -684K -4.75M -1.83M -23.85M -1.84M -1.8M -75.37M
Net Debt 651K 560K 531K 481K 902K 62.15M 907K 6.3M 2.42M 31.62M 2.44M 2.39M 99.91M 608K 524K 496K 449K 843K 58.06M 847K 5.89M 2.26M 29.54M 2.28M 2.23M 93.33M
Logo Lord Global Corporation
27 Health Holdings Corp., formerly Lord Global Corporation, is focused on the business development of its 27Health Inc. subsidiary. 27Health Inc. is focused on financing and marketing, healthcare-related products. The Company distributes the Virolens product in Asia, Australia, New Zealand and other Oceania countries. The Virolens system is a COVID-19 screening device based on microscopic holographic imaging and artificial intelligence (AI) software technology. It uses a digital camera attached to a microscope to analyze saliva samples, with the data run through a computer that is trained to identify the virus from other cells, delivering a result in just 20 seconds. The Virolens system was trained to recognize the COVID-19 virus particles in saliva using a range of samples of COVID-19 virus provided by virologists working on the virus at the University of Bristol.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. LRDG Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!